Nov 9 (Reuters) - Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO :
* To hold conference call for investors to provide business update
* Call will consist of overview of current plans and priorities, including
transition plan from Philidor
* Source text for Eikon urn:newsml:reuters.com:*:nCNWHVQBma
* Further company coverage VRX.TO